Frates James M
Amylyx Pharmaceuticals, Inc. · Chief Financial Officer
Frates James M is listed in public filings as officer: Chief Financial Officer. This Frates James M insider trading page organizes Form 4 disclosures, reported purchases and sales, transaction dates, share amounts, related issuers, and historical insider activity so readers can review the person's public trading record in one place. Companies and tickers connected to this insider trading profile include Amylyx Pharmaceuticals, Inc. (AMLX), and Sage Therapeutics, Inc. (SAGE). Investors use Frates James M's insider trading disclosures to study buying and selling patterns, position changes, company-specific activity, and the source evidence behind each reported transaction.
Latest Actions
| Company | Holding Value | Last Transaction | Amount | Transaction Price | Current Price |
|---|---|---|---|---|---|
| $2.0M144k shares | Grant / ExerciseMar 5, 2026 | $2.0M144k shares | $14.10 | -- | |
| --261.6k shares | Grant / ExerciseMar 5, 2026 | Disclosure amount unavailable96k shares | -- | -- |